• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Roche subsidiary Genentech to acquire Jecure Therapeutics pharmaceutical-technology
    November 30, 2018
    Swiss firm Roche Group’s affiliate Genentech has agreed to acquire US biotechnology company Jecure Therapeutics to strengthen its position in the treatment of liver diseases.....
  • Genentech Acquires Jecure Therapeutics americanpharmaceuticalreview
    November 29, 2018
    Jecure Therapeutics announced a definitive agreement by which it will be acquired by Genentech, a member of the Roche Group. With this acquisition, Genentech will obtain full rights to Jecure’s entire preclinical portfolio of NLRP3 inhibitors......
  • Roche inks deal to purchase Jecure Therapeutics firstwordpharma
    November 28, 2018
    Roche's Genentech unit has entered into a definitive agreement to acquire Jecure Therapeutics, obtaining full rights to the latter’s entire preclinical portfolio of NLRP3 inhibitors, Jecure announced Tuesday. Financial terms of the deal were not divulged.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service